1 - 25 of 57 results for author:"Lynch K.R." in Literature citations
Results Customize
› Repeat search in UniProtKB (69)
| Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury. Bajwa A., Huang L., Ye H., Dondeti K., Song S., Rosin D.L., Lynch K.R., Lobo P.I., Li L., Okusa M.D. J. Immunol. 189:2584-2596(2012) · Mapped (1) |
| Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. Kharel Y., Raje M., Gao M., Gellett A.M., Tomsig J.L., Lynch K.R., Santos W.L. Biochem. J. 447:149-157(2012) · Mapped (11) |
| Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Awad A.S., Rouse M.D., Khutsishvili K., Huang L., Bolton W.K., Lynch K.R., Okusa M.D. Kidney Int. 79:1090-1098(2011) · Mapped (5) |
| Selective activation of sphingosine 1-phosphate receptors 1 and 3 promotes local microvascular network growth. Sefcik L.S., Aronin C.E., Awojoodu A.O., Shin S.J., Mac Gabhann F., MacDonald T.L., Wamhoff B.R., Lynch K.R., Peirce S.M., Botchwey E.A. Tissue Eng Part A 17:617-629(2011) · Mapped (5) |
| Regulation of learning and memory by meningeal immunity: a key role for IL-4. Derecki N.C., Cardani A.N., Yang C.H., Quinnies K.M., Crihfield A., Lynch K.R., Kipnis J. J. Exp. Med. 207:1067-1080(2010) · Mapped (5) |
| Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. Bajwa A., Jo S.K., Ye H., Huang L., Dondeti K.R., Rosin D.L., Haase V.H., Macdonald T.L., Lynch K.R., Okusa M.D. J. Am. Soc. Nephrol. 21:955-965(2010) · Mapped (4) |
| Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo. Tomsig J.L., Snyder A.H., Berdyshev E.V., Skobeleva A., Mataya C., Natarajan V., Brindley D.N., Lynch K.R. Biochem. J. 419:611-618(2009) · Mapped (1) |
| Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury. Jo S.K., Bajwa A., Ye H., Vergis A.L., Awad A.S., Kharel Y., Lynch K.R., Okusa M.D. Kidney Int. 75:167-175(2009) · Mapped (11) |
| Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. Li M.H., Sanchez T., Pappalardo A., Lynch K.R., Hla T., Ferrer F. Mol. Cancer Res. 6:1649-1656(2008) · Mapped (7) |
| Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Wamhoff B.R., Lynch K.R., Macdonald T.L., Owens G.K. Arterioscler. Thromb. Vasc. Biol. 28:1454-1461(2008) · Mapped (1) |
| Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Hughes J.E., Srinivasan S., Lynch K.R., Proia R.L., Ferdek P., Hedrick C.C. Circ. Res. 102:950-958(2008) · Mapped (6) |
| Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69. Srinivasan S., Bolick D.T., Lukashev D., Lappas C., Sitkovsky M., Lynch K.R., Hedrick C.C. Diabetes 57:484-493(2008) · Mapped (5) |
| Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. Oo M.L., Thangada S., Wu M.T., Liu C.H., Macdonald T.L., Lynch K.R., Lin C.Y., Hla T. J. Biol. Chem. 282:9082-9089(2007) · Mapped (3) |
| Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Awad A.S., Ye H., Huang L., Li L., Foss F.W. Jr., Macdonald T.L., Lynch K.R., Okusa M.D. Am. J. Physiol. Renal Physiol. 290:F1516-24(2006) · Mapped (1) |
| Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. Kharel Y., Lee S., Snyder A.H., Sheasley-O'neill S.L., Morris M.A., Setiady Y., Zhu R., Zigler M.A., Burcin T.L., Ley K. et al. J. Biol. Chem. 280:36865-36872(2005) · Mapped (3) |
| Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA). Lee S., Lynch K.R. Biochem. J. 391:317-323(2005) · UniProtKB (1) |
| The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner. Bektas M., Barak L.S., Jolly P.S., Liu H., Lynch K.R., Lacana E., Suhr K.B., Milstien S., Spiegel S. Biochemistry 42:12181-12191(2003) · Mapped (1) |
| Novel human G-protein-coupled receptors. Vanti W.B., Nguyen T., Cheng R., Lynch K.R., George S.R., O'Dowd B.F. Biochem. Biophys. Res. Commun. 305:67-71(2003) · Mapped (5) |
| PGE(2) receptors and synthesis in human gastric mucosa: perturbation in cancer. Takafuji V.A., Evans A., Lynch K.R., Roche J.K. Prostaglandins Leukot. Essent. Fatty Acids 66:71-81(2002) · Mapped (1) |
| The immune modulator FTY720 targets sphingosine 1-phosphate receptors. Brinkmann V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., Bruns C., Prieschl E., Baumruker T., Hiestand P. et al. J. Biol. Chem. 277:21453-21457(2002) · Mapped (2) |
| Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5 (Edg-8): structure-activity relationship of sphingosine1-phosphate receptors. Im D.-S., Clemens J., Macdonald T.L., Lynch K.R. Biochemistry 40:14053-14060(2001) · UniProtKB (2) · Mapped (2) |
| Discovery and mapping of ten novel G protein-coupled receptor genes. Lee D.K., Nguyen T., Lynch K.R., Cheng R., Vanti W.B., Arkhitko O., Lewis T., Evans J.F., George S.R., O'Dowd B.F. Gene 275:83-91(2001) · UniProtKB (10) |
| Identification of a molecular target of psychosine and its role in globoid cell formation. Im D.-S., Heise C.E., Nguyen T., O'Dowd B.F., Lynch K.R. J. Cell Biol. 153:429-434(2001) · UniProtKB (1) |
| Discovery of a novel member of the histamine receptor family. Nguyen T., Shapiro D.A., George S.R., Setola V., Lee D.K., Cheng R., Rauser L., Lee S.P., Lynch K.R., Roth B.L. et al. Mol. Pharmacol. 59:427-433(2001) · UniProtKB (1) |
| Identification of four novel human G protein-coupled receptors expressed in the brain. Lee D.K., George S.R., Cheng R., Nguyen T., Liu Y., Brown M., Lynch K.R., O'Dowd B.F. Brain Res. Mol. Brain Res. 86:13-22(2001) · UniProtKB (4) |